crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …

-deals as part of pharmaceutical patent settlements in the European Union. First, this paper critically discusses and compares … side-deals that were part of the patent settlements in the Servier case, which is currently pending on appeal. Second, the … outlined, focusing on the CJEU’s analysis of the side-deals that were part of the patent settlements at issue. The core …

This submission takes a public policy perspective, focusing on the public return from the patent system through … competition based on the new technology after the 20-year patent monopoly period expires. The government has agreed time …-limited monopolies to encourage domestic invention (the patent system). At the end of the agreed period, the patented invention should be …

of agreements by which brand-name drug companies pay generics to settle patent litigation and delay entering the market … of the patent" test applied by the dissent and several appellate courts — would have meant "game over" for challenges to …

crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …